From Blind To Intelligent Navigation in Breast Biopsy Procedures

https://www.mayoclinic.org/tests-procedures/breast-biopsy/about/pac-20384812

The development of breast biopsy procedures is a history of humanity's continuous pursuit of precision, minimal invasiveness, and efficiency. From initial blind trials to today's stereotactic and molecular navigation, the form and function of the biopsy needle have undergone tremendous changes. Reviewing this history not only helps us understand the advantages of current technologies but also provides insights into future development trends.

Early Exploration: The Birth of Fine-Needle Aspiration Cytology (FNA)

In the mid-20th century, with advancements in cytology techniques, fine-needle aspiration (FNA) began to be applied to the diagnosis of breast lesions. At that time, most biopsy needles were ordinary injection needles (20G-22G), and the procedure relied primarily on the physician's palpation. While this "blind" method was simple, it had a high rate of missed diagnoses and false negatives for deep or inaccessible lesions. However, FNA laid the foundation for minimally invasive biopsy, proving the possibility of obtaining diagnostic information through minimal trauma.

The Era of Imaging-Guided Biopsy: Opening the Door to Precision

The widespread adoption of ultrasound and mammography in the 1980s revolutionized breast biopsy procedures.

* Ultrasound Guidance: In the 1980s, real-time ultrasound imaging allowed doctors to "see" the needle tip and lesions. Specialized biopsy needles were developed, with continuous optimization of needle markings and bevel designs to improve ultrasound visibility.

* Stereotactic Positioning: In the late 1980s, stereotactic biopsy systems emerged, specifically designed for detecting microcalcifications using mammography. The invention of the spring-loaded biopsy gun was a milestone during this period, using mechanical power to instantly fire the needle, significantly reducing puncture time, patient pain, and tissue displacement.

Vacuum-Assisted Biopsy (VAB): A Leap from Diagnosis to Treatment

The mid-1990s saw the advent of vacuum-assisted biopsy systems (such as the Mammotome), marking a new era in breast biopsy procedures. Unlike traditional cutting needles, the VAB system utilizes vacuum negative pressure to draw tissue into the sampling chamber, followed by rotary cutting. This allows for the acquisition of large amounts of tissue in a single insertion, making it particularly suitable for biopsies of microcalcifications and lobular carcinomas. Needles have also evolved from simple cutting instruments into precision instruments integrating aspiration, cutting, and delivery.

Advances in Materials Science and Manufacturing Processes

Accompanying technological development is innovation in materials science. The processing precision of stainless steel needles has continuously improved, and the geometry of the needle tip (such as the Tri-Cut tip) has been optimized through hydrodynamics to reduce puncture resistance. The application of titanium alloys has solved MRI compatibility issues. Injection molding technology for polymer materials has made it possible to manufacture polymer needles with complex structures, such as aspiration needles with side holes.

Digitalization and Intelligentization: The Future Direction

Entering the 21st century, breast biopsy procedures are moving towards intelligentization and automation.

* Electromagnetic Navigation: By implanting miniature electromagnetic sensors within the puncture needle, the system can track the position of the needle tip in three-dimensional space in real time and fuse it with preoperative CT/MRI images, enabling precise navigation even without real-time imaging.

* Robot-Assisted: Robotic biopsy systems (such as iSR'obot™ Mona Lisa) are already used clinically. They can control the puncture path with sub-millimeter precision, reducing human hand tremors and are particularly suitable for biopsies of extremely small lesions.

* AI-Assisted Diagnosis: Artificial intelligence algorithms are being used to analyze ultrasound images, automatically identify the optimal puncture point and needle path, and even predict the benign or malignant nature of biopsy results, assisting doctors in decision-making.

Looking to the Future: Nanoneedles and Biosensors

Future breast biopsy procedures may become even more microscopic. The application of nanotechnology may give rise to "nanoneedles" with diameters only in the micrometer range, used for single-cell level biopsies. Biosensors integrated into the needle tip can monitor tissue biochemical indicators (such as pH, oxygen partial pressure, and specific protein concentrations) in real time during puncture, achieving "instant diagnosis."

From a simple steel needle to today's high-tech integrated equipment, the evolution of breast biopsy procedures reflects the progress of medical technology as a whole. Every technological innovation revolves around the same goal: to minimize patient discomfort and obtain the most accurate diagnosis. As clinicians, understanding this history allows us to better grasp the present and embrace the future.